Clinical trial

Association of Capecitabine Pharmacokinetics and Toxicity With Aging

NCT03465202

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2016-05-01

PhasePHASE4

Study timeline

Study start (unknown)2016-05-01Date precision: month

Registry last updated2018-03-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Colorectal Cancerunresolved

Interventions

CapecitabineDRUG · verified · RxNorm: capecitabine

Sponsors & collaborators

Newcastle-upon-Tyne Hospitals NHS Trustlead sponsor

University of Newcastle Upon-Tynecollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03465202 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.